We believe both mechanisms are involved since numerous studies have shown that YKL-40 is related to metabolic syndrome and its components (hypertension, hyperlipidemia, cardiovascular and cerebrovascular diseases), various cancers, obstructive sleep apnea syndrome, chronic allograft nephropathy, and Alzheimer disease [15,24–27]. The gene discussed is CHI3L1; the disease is cerebrovascular disorder.